1. Home
  2. COUR vs SLNO Comparison

COUR vs SLNO Comparison

Compare COUR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$7.45

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$47.75

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COUR
SLNO
Founded
2012
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
2.5B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
COUR
SLNO
Price
$7.45
$47.75
Analyst Decision
Buy
Strong Buy
Analyst Count
12
10
Target Price
$12.33
$110.90
AVG Volume (30 Days)
4.0M
1.3M
Earning Date
01-29-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$739,774,000.00
$98,675,000.00
Revenue This Year
$10.46
N/A
Revenue Next Year
$6.00
$155.86
P/E Ratio
N/A
N/A
Revenue Growth
8.09
N/A
52 Week Low
$5.76
$41.50
52 Week High
$13.56
$90.32

Technical Indicators

Market Signals
Indicator
COUR
SLNO
Relative Strength Index (RSI) 35.67 42.01
Support Level $7.33 $47.01
Resistance Level $8.89 $49.75
Average True Range (ATR) 0.37 2.37
MACD -0.03 0.12
Stochastic Oscillator 8.31 8.91

Price Performance

Historical Comparison
COUR
SLNO

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: